Amgen and Micromet have entered into a definitive merger agreement under which Amgen will acquire Micromet for $11 per share in cash more »

Definitive agreement under which Gilead will acquire Pharmasset for $137 per share in cash more »

Definitive agreement under which Cubist will acquire all of the outstanding shares of Adolor for $4.25 per share in cash more »

Definitive merger agreement under which it will be acquired by affiliates of The Carlyle Group and Hellman & Friedman more »

Alkermes – Elan Drug Technologies: Cash and stock transaction currently valued at approximately $960 million more »

Express Scripts – Medco Health Solutions: The merger will combine the expertise of two complementary pharmacy benefit managers (PBMs) to accelerate efforts to lower the cost of prescription drugs and improve the quality of care for Americans more »

Kinetic Concepts – Apax Partners: Definitive merger agreement under which a consortium comprised of funds advised by Apax Partners more »

Ashland – International Specialty Products: Ashland has agreed to acquire privately owned ISP, a global specialty chemical manufacturer of innovative functional ingredients and technologies more »

Watson Pharmaceuticals – Specifar Pharma: Watson has acquired the privately-held multinational generic pharmaceutical developer, manufacturer and marketer for EUR 400 million ($562 million) in cash and certain contingent consideration more »